Herrmann Einsele

Wuerzburg, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study.

Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study.

Journal: Blood advances
Published: May 09, 2022

Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT.

Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 20, 2020

Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia.

Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia.

Journal: Current research in translational medicine
Published: March 13, 2018

[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values.

[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values.

Journal: Theranostics
Published: June 23, 2016

Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.

Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.

Journal: Nature medicine
Published: January 11, 2016

11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.

11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.

Journal: Oncotarget
Published: November 26, 2014

18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.

18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.

Journal: Oncotarget
Published: October 04, 2014

Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.

Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.

Journal: PloS one
Published: August 20, 2013

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Journal: The Lancet. Oncology
Published: September 11, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026